🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UK Stocks-Factors to watch on Feb 6

Published 06-02-2020, 11:28 am
Updated 06-02-2020, 11:31 am
© Reuters. UK Stocks-Factors to watch on Feb 6

Feb 6 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 42 points higher on Thursday, according to financial bookmakers.

* ECONOMY: The goal of British finance minister Sajid Javid of doubling the pace of economic growth has only a one-in-five chance of success, a think tank said, citing the huge task of snapping the country out of its chronic run of poor productivity. CONSTRUCTION: The number of new homes registered for construction in Britain last year inched up to the highest since 2007, boosted by London's recovery from the previous year's Brexit-induced drop, industry figures showed. TRADE DEAL: British Foreign Secretary Dominic Raab hopes a free trade deal with Australia will be one of the first such pacts to be secured, now that Britain has left the European Union, he said. SHELL: Royal Dutch Shell RDSa.L , which plans billions of dollars in spending on shale drilling projects, boosted output in the top U.S. shale field to 250,000 barrels per day in December, the company's Permian Basin head said on Wednesday. EX-DIVS: Sage Group SGE.L will trade without entitlement to their latest dividend pay-out on Thursday. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-makers would have a very marginal impact on the index. OIL: Oil futures rose for a second day on Thursday amid investor optimism over unconfirmed reports of possible advances in combating the coronavirus outbreak in China as a sign fuel demand may rebound in the world's biggest oil importer. GOLD: Gold prices fell as strong U.S. economic data boosted risk appetite and the dollar, while investors kept a cautious eye on the virus outbreak as the death toll jumped past 500. UK shares got a shot in the arm on Wednesday after media reports that scientists had developed a drug against the China-linked coronavirus, though Imperial Brands (LON:IMB) and GlaxoSmithKline missed out after downbeat financial updates. UK CORPORATE DIARY:

Compass Group CPG.L

Trading Update Beazley

BEZG.L FY Results Royal Mail


Trading Statement Tate & Lyle

TATE.L Q3 Trading Update Victrex

VCTX.L Q1 Interim Management Statement Cranswick


Q3 Trading Update Superdry

SDRY.L Trading Update Ashmore

ASHM.L HY Results


> Financial Times


> Other business headlines


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.